http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
( Hyun Jik Lee ),( Chang Min Cho ),( Jun Heo ),( Min Kyu Jung ),( Tae Nyeun Kim ),( Kook Hyun Kim ),( Hyunsoo Kim ),( Kwang Bum Cho ),( Ho Gak Kim ),( Jimin Han ),( Dong Wook Lee ),( Yoon Suk Lee ) 대한간학회 2020 Gut and Liver Vol.14 No.2
Background/Aims: Few studies have addressed the relationship between the occurrence of adverse events (AEs) in endoscopic retrograde cholangiopancreatography (ERCP) and hospital case volume or endoscopist’s experience with inconsistent results. The aim of our study was to investigate the impact of hospital case volume and endoscopist’s experience on the AEs associated with ERCP and to analyze patient- and procedure-related risk factors for post-ERCP AEs. Methods: From January 2015 to December 2015, we prospectively enrolled patients with naïve papilla who underwent ERCP at six centers. Patient- and procedure-related variables were recorded on data collection sheets at the time of and after ERCP. Results: A total of 1,191 patients (median age, 71 years) were consecutively enrolled. The overall success rate of biliary cannulation was 96.6%. Overall, 244 patients (20.5%) experienced post-ERCP AEs, including pancreatitis (9.0%), bleeding (11.8%), perforation (0.4%), cholangitis (1.2%), and others (0.9%). While post-ERCP pancreatitis (PEP) was more common when the procedure was performed by less experienced endoscopists, bleeding was more common in high-volume centers and by less experienced endoscopists. Multivariate analysis showed that a less experience in ERCP was significantly associated with PEP (odds ratio [OR], 1.630; 95% confidence interval [CI], 1.050 to 2.531; p=0.030) and post-ERCP bleeding (OR, 1.439; 95% CI, 1.003 to 2.062; p=0.048). Conclusions: Our study demonstrated that overall AEs following ERCP were associated with the experience of the endoscopist. To minimize post-ERCP AEs, rigorous training with a sufficient case volume is required, and treatment strategies should be modified according to the endoscopist’s expertise.
Comparative study on antioxidant activity of Gold 1, a new strain of Pyropia yezoensis
Jimin Hyun,Sang-Woon Lee,Hyeon Hak Jeong,김재일 한국수산과학회 2023 Fisheries and Aquatic Sciences Vol.26 No.2
The global output of Pyropia yezoensis (dried seaweed or laver, also called ‘Gim’ in Korea) has been reduced over the half-decade due to the wide spread of red rot disease, a serious algal disease affecting P. yezoensis. Recently, Gold 1 (G1), which is a resistant strain of P. yezoensis to red rot disease, was developed and commercialized in South Korea, yet its physiological activity has not been investigated. In this study, a comparative study was performed on G1 and commercially available strain of P. yezoensis (CP) for their antioxidative activities. Aqueous extract of G1 showed more marked 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) radical scavenging activity compared to that of CP. In 293T cells, antioxidant activity against H2O2-induced reactive oxygen species (ROS) formation was only observed in G1 extract. In addition, G1 extract showed more potent inhibitory effect on H2O2-induced apoptotic cell death than CP extract, as examined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and fluorescence microscopy. Expression levels of various apoptosis-related genes, including B-cell lymphoma 2-associated X protein, p53, capase-3, and inflammatory cytokines, in H2O2-treated cells were significantly decreased by the treatment of G1. Taken together, the present study suggests that a new strain of red seaweed G1 can recover oxidative stress effectively by improving the imbalance of ROS generation and has a potential to be used a functional ingredient as an antioxidant source.
급성췌장염에서 애틀랜타 분류 개정안 적용과 임상경과 예측: 후향적, 다기관 연구
이현철 ( Hyun Chul Lee ),김현희 ( Hyun Hee Kim ),한지민 ( Jimin Han ),이동욱 ( Dong Wook Lee ),김호각 ( Ho Gak Kim ),허준 ( Jun Heo ),정민규 ( Min Kyu Jung ),조창민 ( Chang Min Cho ),조광범 ( Kwang Bum Cho ),김국현 ( Kook Hyun Ki 대한췌장담도학회 2015 대한췌담도학회지 Vol.20 No.2
Background/Aims: The 2012 revision of the Atlanta classification of acute pancreatitis (AP) by international consensus has been published and in use. This study investigated and compared clinical outcome of patients with AP stratified according to the 1992 Atlanta classification and revised classification. Methods: A total of 574 AP patients from six referral hospitals between January 2012 and July 2013 were included. Medical records were reviewed retrospectively. Severity assessment according to both classifications was done. Demographics, organ failure, local complications, length of stay, and clinical outcome were recorded. Results: There were 377 males (65.7%). Median age was 55.4 years. Two most common causes of AP were alcohol (n=238, 41.5%) and gallstone (n=193, 33.6%). According to revised classification, there were mild (n=356, 62%), moderately severe (n=197, 34.3%), and severe AP (n=21, 3.7%). Length of stay showed gradual increment with increase in degrees of severity according to the revised classification (5.9 days in mild AP, 8.3 days in moderately severe AP, and 13 days in severe AP, p<0.001). All the patients with mild and moderately severe AP improved, but all the 11 cases without improvement belonged to severe AP. Conclusions: The revised classification seems to be a good predictor for clinical outcome of AP. Korean J Pancreatobiliary 2015;20(2):64-70
Lee, Ji Hyun,Choi, Jimin,Kwon, Kyung A,Lee, Suee,Oh, Sung Yong,Kwon, Hyuk-Chan,Kim, Hyo-Jin,Han, Jin Yeong,Kim, Sung-Hyun Korean Society of Hematology; Korean Society of Bl 2010 Blood Research Vol.45 No.2
<P><B>Background</B></P><P>A combination of busulfan (Bu) and cyclophosphamide (Cy) has been used as a standard myeloablative regimen for allogeneic hematopoietic stem cell transplantation (HSCT). Recent studies postulate that fludarabine (Flu) is a less toxic substitute for Cy.</P><P><B>Methods</B></P><P>Forty-two patients who were diagnosed with acute leukemia or myelodysplastic syndrome and received BuFlu (n=17) or BuCy (n=25) from August, 1999 to July, 2009 at Dong-A University Medical Center were retrospectively analyzed.</P><P><B>Results</B></P><P>The median follow-up duration was 39.75 months. The BuFlu group showed a lower incidence of mucositis (<I>P</I>=0.005), but there was no significant intergroup difference in the time of engraftment, nausea/vomiting, acute/chronic graft-versus-host disease, hepatic veno-occlusive disease, or hemorrhagic cystitis. Moreover, the 2 groups showed no significant difference in the cumulative risk of relapse, event-free survival, or overall survival.</P><P><B>Conclusion</B></P><P>BuFlu administration can be employed as a preparative regimen for allogeneic HSCT and shows efficacy and transplant-adverse effects comparable to those of BuCy. However, randomized prospective studies in more patients are warranted.</P>
Jimin Kim,Keun-Young Lee,Kwang-Wook Kim,Eil-Hee Lee,Dong-Yong Chung,Jei-Kwon Moon,Jae-Hyuk Hyun 한국방사성폐기물학회 2017 방사성폐기물학회지 Vol.15 No.1
본 연구에서는 고염/고방사성 폐액 내 함유된 주요 고방사성핵종인 Cs 제거를 목적으 로 고효율의 복합 흡착제(potassium cobalt ferrocyanide (PCFC)-loaded chabazite (CHA)) 합성 및 이의 적용성을 평가하 였다. 복합 흡착제는 Cs을 비롯한 다 른 입자를 수용할 수 있는 CHA를 지지체로 선정하였으며, CoCl2 및 K4Fe(CN)6 용액 의 단계적인 함침/침전을 통해 PCFC를 CHA 세공 내에 고정화함으로써 합성하였다. 복합 흡착제의 합성 시 평균 입자크기가 10 ㎛ 이상의 CHA를 지지체로 사용할 경우, PCFC 입자는 안정적인 형태로 고정화되었다. 또한, 합성 시 복합 흡착제의 정 제를 증가시키는 세척 방법을 최적화함 으로써, 복합 흡착제의 물리적 안정성이 향상되었다. 최적의 합성법을 통해 얻은 복합 흡착제에 의한 Cs 흡착 시, 담수(무염 조건) 및 해수(고염 조건)에서 모두 빠른 흡착 속도를 보였으며, 염 농도와 무관하게 비교적 높은 분배계수 값(104 mL·g-1 이상)을 나타내었다. 그러므로, 본 연구에서 합성한 복합 흡착제는 CHA 및 PCFC가 각각 가지고 있는 물리적 안정성과 Cs 에 높은 선택성 등을 고려하여 촤적화한 소재이며, 고염/고방사성폐액에 함유되어 있 는 Cs을 고효율로 신속하게 제거할 수 있음을 알 수 있다. For the removal of cesium (Cs) from high radioactive/high salt-laden liquid waste, this study synthesized a highly efficient composite adsorbent (potassium cobalt ferrocyanide (PCFC)-loaded chabazite (CHA)) and evaluated its applicability. The composite adsorbent used CHA, which could accommodate Cs as well as other molecules, as a supporting material and was synthesized by immobilizing the PCFC in the pores of CHA through stepwise impregnation/precipitation with CoCl2 and K4Fe (CN)6 solutions. When CHA, with average particle size of more than 10 ㎛, is used in synthesizing the composite adsorbent, the PCFC particles were immobilized in a stable form. Also, the physical stability of the composite adsorbent was improved by optimizing the washing methodology to increase the purity of the composite adsorbent during the synthesis. The composite adsorbent obtained from the optimal synthesis showed a high adsorption rate of Cs in both fresh water (salt-free condition) and seawater (high-salt condition), and had a relatively high value of distribution coefficient (larger than 104 mL·g-1) regardless of the salt concentration. Therefore, the composite adsorbent synthesized in this study is an optimized material considering both the high selectivity of PCFC on Cs and the physical stability of CHA. It is proved that this composite adsorbent can remove rapidly Cs contained in high radioactive/high salt-laden liquid waste with high efficiency.